“Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)” Research Letter
| Authors: | Rasmussen, B.; Göhring, G.; Bernard, E.; Nilsson, L.; Tobiasson, M.; Jädersten, M.; Garelius, H.; Dybedal, I.; Grønbaek, K.; Ejerblad, E.; Lorenz, F.; Flogegård, M.; Marcher, C. W.; Öster Fernström, A.; Cavelier, L.; Papaemmanuil, E.; Ebeling, F.; Kittang, A. O.; Nørgaard, J. M.; Saft, L.; Möllgård, L.; Hellström-Lindberg, E. |
| Title: | “Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)” |
| Keywords: | controlled study; genetics; leukemia, myeloid, acute; lenalidomide; clinical trial; phase 2 clinical trial; randomized controlled trial; myelodysplastic syndrome; chromosome deletion; karyotype; azacitidine; myelodysplastic syndromes; chromosome 5; chromosomes, human, pair 5; acute myeloid leukemia; humans; human |
| Journal Title: | Leukemia |
| Volume: | 36 |
| Issue: | 5 |
| ISSN: | 0887-6924 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2022-05-01 |
| Start Page: | 1436 |
| End Page: | 1439 |
| Language: | English |
| DOI: | 10.1038/s41375-022-01537-w |
| PUBMED: | 35277655 |
| PROVIDER: | scopus |
| PMCID: | PMC9061286 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 June 2022 -- Source: Scopus |
